UBS Group »

Aim Immunotech shares owned by UBS Group

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $832 304 2.74
2025-06-30 $10k 1.2k 8.65

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Aim Immunotech

DRW Holdings
Sabby Management
Vanguard Group
Geode Capital Management
Morgan Stanley
UBS Group
Community Bank
Pnc Financial Services
Advisor Group Holdings
Hoey Investments
Harbour Investments
Wells Fargo & Company
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech